The goal of this module is to describe the clinical implications of the changes in the conceptualization of BD across DSM editions, including the specificati
Supported by an independent educational grant from Intra-Cellular Therapies, Inc.
All Education
The goal of this module is to assess and differentiate between BD-I, BD-II, MDD, and related disorders in accordance with current diagnostic criteria and guidelines.
The goal of this module is to evaluate the limitations of conventional treatments and the optimal role of newer treatments for BD, based on their proposed MOAs, approved indications, and latest saf
The goal of this module is to implement actionable strategies for minimizing and managing cardiometabolic risks associated with BD pharmacotherapy.
